Page 3,067«..1020..3,0663,0673,0683,069..3,0803,090..»

Dance helps people with Parkinsons, maybe healthy senior citizens, too

Posted: Published on December 5th, 2014

Health and Medicine for Seniors Dance helps people with Parkinsons, maybe healthy senior citizens, too Ballroom dancing could help people with Parkinsons improve their balance and mobility, and maybe do the same for other seniors By Tucker Sutherland, editor, SeniorJournal.com Dec. 4, 2014 Researchers at the University of Southhampton, UK, recently announced that participants in their study who had Parkinsons and took part in ballroom dance lessons improved their balance, confidence and posture. They are not the first to discover that dancing can make life better and safer for Parkinsons patients, who are also almost exclusively senior citizens. Maybe seniors without PD should also consider how this exercise reduced falls in the PD group. One clear risk factor for Parkinson's is age. The average age of onset is 60 years and the risk rises significantly with advancing age. In one year, a third of people over 65 will have a fall, but two thirds of people with Parkinsons will experience a fall. After an initial fall, or if people start to be unsteady, they could develop a fear of falling which will then have an impact on their mobility and result in reliance on a caregiver or a healthcare service. … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Dance helps people with Parkinsons, maybe healthy senior citizens, too

How Are CTE and Behavior Linked? The Answer Requires More in-Depth Research, Scientists Say

Posted: Published on December 5th, 2014

Contact Information Available for logged-in reporters only Newswise BUFFALO, N.Y. Aggression, violence, depression, suicide. Media reports routinely link these behavioral symptoms with chronic traumatic encephalopathy (CTE), the neurodegenerative brain disease, in former football players. But just how CTE and behavioral changes are related is an extremely complex and, as yet, poorly understood issue, write University at Buffalo researchers in a new research paper. Published last month in the Journal of Neuropsychiatry and Clinical Neurosciences, the UB paper traces the reporting of neuropsychiatric symptoms now associated with CTE back to the 1928 publication by H.S. Martland in the Journal of the American Medical Association titled Punch Drunk. That publication chronicled behavioral problems in individuals, presenting as cuckoo, goofy, or slug nutty, following one or more blows to the head. Martland discussed the similarity of these symptoms to other brain disorders that involved encephalitis, inflammation of the brain. Since then, the UB researchers write, discussion of these symptoms has evolved as new technologies have helped identify specific brain changes that occur after blows to the head result in forces being transferred to the brain. The UB researchers conclude that the paucity of longitudinal, prospective studies on CTE and the absence of research-accepted … Continue reading →

Posted in Brain Injury Treatment | Comments Off on How Are CTE and Behavior Linked? The Answer Requires More in-Depth Research, Scientists Say

CereScan Corp. Selected to Join Cavendish Global and Present at Health Impact Forums

Posted: Published on December 5th, 2014

Littleton, CO (PRWEB) December 04, 2014 CereScan, a national leader in functional brain diagnostics and molecular imaging, was selected as an Innovation Partner and invited to present at the Cavendish Global Health Impact Forums that took place November 10-13th at Oxford University in the UK and will take place April 27-30, 2015 in San Diego. The Health Impact Forums help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within the health and life sciences. To accomplish this mission, the Forums showcase presentations and panel discussions by leading scientists, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. Michael Moffat, Cavendish co-founder and President explains, With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. CereScans advanced technologies and pioneering research clearly qualified them as an Innovation Partner and we are delighted that they have joined the Cavendish family. We are honored to be selected as an Innovation Partner and to present our leading-edge research at these … Continue reading →

Posted in Brain Injury Treatment | Comments Off on CereScan Corp. Selected to Join Cavendish Global and Present at Health Impact Forums

MS Treatment Plan – Video

Posted: Published on December 5th, 2014

MS Treatment Plan Nov 4, 2014. By: Pamela Makela … Continue reading →

Posted in MS Treatment | Comments Off on MS Treatment Plan – Video

First MS patients treated with Genzymes Lemtrada in US

Posted: Published on December 5th, 2014

PBR Staff Writer Published 04 December 2014 Genzyme has announced that the first patient with relapsing forms of multiple sclerosis (MS) has been treated with Lemtrada (alemtuzumab). Due to its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS. Lemtrada has two annual treatment courses, the first is administered via intravenous infusion on five consecutive days, while the second is administered on three consecutive days, 12 months later. North Central Neurology Associates founder Christopher LaGanke said: "As an investigator in the Phase III clinical development program with firsthand experience, I have been awaiting the ability to prescribe Lemtrada to patients in my practice who could potentially benefit from this treatment. "Following REMS training and certification, I am excited that I was able to become the first physician to initiate patient treatment in the United States." In November, the FDA approved Lemtrada based on two pivotal randomized Phase III open-label rater-blinded studies comparing treatment with Lemtrada to Rebif in patients with relapsing remitting MS who were either new to treatment (CARE-MS I) or who had relapsed while on prior therapy (CARE-MS … Continue reading →

Posted in MS Treatment | Comments Off on First MS patients treated with Genzymes Lemtrada in US

MS Research Highlights in 2014 Offer New Leads in Stopping MS, Restoring Function Lost, and Ending MS Forever

Posted: Published on December 5th, 2014

NEW YORK, NY (PRWEB) December 04, 2014 Significant research progress occurred in 2014, offering new leads that are driving efforts to stop MS, restore function lost, and end MS forever. In 2014, the National Multiple Sclerosis Society invested $50.6 million in 380 new and ongoing research projects and initiatives. Here is a brief summary of the research highlights reflecting the Societys commitment to pursue promising opportunities wherever they exist, while focusing on three priority areas: progressive MS, nervous system repair, and wellness/lifestyle, which have been singled out under each research goal below when applicable. I. STOPPING MS ---Progressive MS--- ---Lifestyle/Wellness--- II. RESTORING WHATS BEEN LOST ---Nervous System Repair--- ---Lifestyle/Wellness--- III. ENDING MS FOREVER ---Lifestyle/Wellness--- Here is the original post: MS Research Highlights in 2014 Offer New Leads in Stopping MS, Restoring Function Lost, and Ending MS Forever … Continue reading →

Posted in MS Treatment | Comments Off on MS Research Highlights in 2014 Offer New Leads in Stopping MS, Restoring Function Lost, and Ending MS Forever

Side Effects Associated with Low T Prescription Drugs

Posted: Published on December 5th, 2014

Many men that suffer from low testosterone (also known as Low T) are taking hormone replacement therapy drugs that are linked to serious health concerns including heart attack and stroke. Several studies associate certain testosterone replacement therapy (TRT) drugs to an increased risk of cardiovascular problems such as heart attack, stroke, or deep vein thrombosis. Advocacy groups have called for updated black-box warnings to be included on all testosterone packages. These groups have also petitioned the U.S. Food and Drug Administration (FDA) to require Low T drug manufacturers to include warnings on the labels currently on the market. Testosterone Therapy and Use of Low T Drugs An estimated 3 to 7 percent of men in the U.S. have hypogonadism (low testosterone) a condition in which the body fails to produce enough hormones due to issues with the pituitary gland or testicles. However, with the advent of several Low T drugs on the market such as AndroGel, Androderm, Axiron, Delatestryl, Fortesta, Striant, Testim, Testopel among others thepercentage of men 40 and older being treated for Low T has more than tripled from 2001 to 2011, according to a USA Today article. The problem is that testosterone levels vary widely and is … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Side Effects Associated with Low T Prescription Drugs

Testosterone in women: How important is it?

Posted: Published on December 5th, 2014

Testosterone is another important hormone necessary for your personal hormonal symphony. Testosterone loss can occur at anytime in a woman's life. Deficiencies can begin with menopause but can also occur after childbirth. Hormone levels are often 'reset' after childbirth, however, not always correctly. Other factors that can lower testosterone levels include: chemotherapy, adrenal stress and burnout, endometriosis, depression, birth control pills, psychological trauma, and statin drugs. Deficiencies occur earlier and initially at a greater rate in women than in men. High amounts of testosterone are consumed, thereby depleting androgen levels, with intense physical activity such as long distance running as well as other vigorous sports. An optimal level of testosterone improves mood and assertiveness, reduces depression and anxiety, improves bone density, muscle size and strength, and enhances libido. It helps maintain memory; however, in a woman, effective levels of estrogen must also be present. It helps stop the skin from sagging, and decreases excess body fat. Symptoms of low testosterone include: muscle wasting, weight gain, fatigue, low self-esteem, decreased HDL cholesterol levels, dry and thin skin with poor elasticity, thinning and dry hair, droopy eyelids, sagging cheeks, thin lips and anxiety. Based on known effects of androgens, it is likely … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Testosterone in women: How important is it?

Stem Cell Research in Long QT Syndrome – Long QT Family Day | Boston Children’s Hospital – Video

Posted: Published on December 5th, 2014

Stem Cell Research in Long QT Syndrome - Long QT Family Day | Boston Children's Hospital Dr. William Pu, Assistant in Cardiology at Boston Children's Hospital, discusses stem cell research in long QT syndrome. Learn more: http://www.childrenshosp... By: Boston Children's Hospital … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Research in Long QT Syndrome – Long QT Family Day | Boston Children’s Hospital – Video

Persusive Video on Stem Cell Research – Video

Posted: Published on December 5th, 2014

Persusive Video on Stem Cell Research Song- Elements by Lindsey Stirling. By: edwin fane … Continue reading →

Posted in Stem Cell Research | Comments Off on Persusive Video on Stem Cell Research – Video

Page 3,067«..1020..3,0663,0673,0683,069..3,0803,090..»